Clinical trials recruiting in Nieuwegein, Netherlands

Phase breakdown

Conditions recruiting in Nieuwegein, Netherlands

Recruiting trials in Nieuwegein, Netherlands

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
  NCT05253651 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
  NCT07181590 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
  NCT06355063 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female)
• Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
  NCT06434896 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
  NCT06784466 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Control Crohn Safe Trial
  NCT03917303 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
  NCT04894838 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Effectiveness of Focal Therapy in Men With Prostate Cancer
  NCT06223295 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: Male
• Evaluation of Ablation Lesions Using Cardiovascular Magnetic Resonance Imaging
  NCT05432024 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Evalutation of a Hybrid Care Pathway With Remote MONitoring for Heart Failure
  NCT07680634 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
  NCT04833426 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
  NCT06567197 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
  NCT06384560 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Optimized Expansion of the Implanted Transcatheter Aortic Valve
  NCT07042529 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
  NCT06168370 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 110 Years · Sex: All (male and female)
• Predictors of Weight Loss and Metabolic Health After Bariatric Surgery
  NCT05987631 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
  NCT06220032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  NCT00271180 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Prospective Data Collection Initiative on Colorectal Cancer
  NCT02070146 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PulseSelect™ PFA Global Registry
  NCT06393920 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer
  NCT07180381 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• The RECLAIM Study.
  NCT06450444 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female)
• The Radium-select Study
  NCT06659926 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• The ReTAVI Prospective Observational Registry
  NCT05601453 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.
  NCT07234422 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Thoracoscopic Surgical Versus Catheter Ablation Approaches for Primary Treatment of Persistent Atrial Fibrillation
  NCT04715425 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort
  NCT02839863 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation
  NCT04228211 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
  NCT04436978 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Nieuwegein, Netherlands?

33 recruiting trials have at least one study site in Nieuwegein, Netherlands.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.